Kennebec Savings Bank’s Supernus Pharmaceuticals SUPN Stock Holding History

Kennebec Savings Bank’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$92K	Hold	1,978	–	–	0.07%	131
2026 Q1	$102K	Hold	1,978	–	–	0.09%	108
2025 Q4	$98.3K	Hold	1,978	–	–	0.08%	113
2025 Q3	$94.5K	Sell	1,978 -1,322	-40%	-$53.2K	0.09%	110
2025 Q2	$104K	Hold	3,300	–	–	0.1%	108
2025 Q1	$108K	Hold	3,300	–	–	0.11%	107
2024 Q4	$124K	Hold	3,300	–	–	0.12%	105
2024 Q3	$103K	Buy	+3,300	New	+$103K	0.1%	112

Other funds holding SUPN

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

CNAM

Campbell Newman Asset Management Milwaukee, Wisconsin $1.35B AUM 38.87% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Kennebec Savings Bank's SUPN Position: Q2 2026 in Review

Kennebec Savings Bank held its Supernus Pharmaceuticals (SUPN) position steady in Q2 2026 at 1,978 shares worth $92K. The position accounts for 0.07% of the portfolio, ranked #131.

Kennebec Savings Bank first reported a position in SUPN in Q3 2024 and has held it in 8 quarters since. The position peaked at $124K in Q4 2024. 65 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

Kennebec Savings Bank held 1,978 shares of Supernus Pharmaceuticals worth $92K as of Q2 2026.
Kennebec Savings Bank left its Supernus Pharmaceuticals share count unchanged in Q2 2026.
Supernus Pharmaceuticals made up 0.07% of Kennebec Savings Bank's portfolio in Q2 2026, its #131 holding.
Kennebec Savings Bank first reported a position in Supernus Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
Kennebec Savings Bank's Supernus Pharmaceuticals position peaked at $124K in Q4 2024.
65 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Kennebec Savings Bank's 13F filing for Q2 2026, filed 13 Jul 2026.